CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $15.00 ($45,000)
- 4 Open-market sale President and CEO sold 6,526 shares at an average $15.00 ($97,899)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $18.46 ($55,380)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.39 ($67,170)
- 4 Open-market sale President and CEO sold 13,052 shares at $21.86 ($285,343)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.05 ($78,150)
- 4 Open-market sale President and CEO sold 4,497 shares at $25.06 ($112,689)
- 4 Open-market sale President and CEO sold 2,028 shares at $25.09 ($50,880)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.56 ($67,680)
- 4 Open-market sale President and CEO sold 13,052 shares at $23.42 ($305,708)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $25.93 ($77,793)
- 4 Grant or award President and CEO acquired 302 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.52 ($79,562)
- 4 Open-market sale President and CEO sold 19,578 shares at $26.55 ($519,743)
Page 12 of 20 · 400 filings